Specific Problems in Perinatal Infections: A Literature Review

Abstract

Although the level of infectious diseases has considerably reduced over time they still remain an important cause of both maternal and perinatal morbidity and mortality. Maternal infections are the fifth leading cause of maternal death and are believed to be the fifth leading cause of death in neonates. Infectious disease is largely preventable and treatable, and as such, reducing the incidence and severity of these infections is a reasonable and achievable goal. Maternal infections range from the relatively innocuous genitourinary tract infections to sepsis and septic shock. Serious infections include those due to Group B streptococci, necrotising enterocolitis and HIV. Group B streptococcal infections can cause several disease states, including pneumonia, sepsis and meningitis in neonates and newborns. With universal application of screening and prophylaxis protocols, this disease can be drastically reduced. Necrotising enterocolitis is a multi-factorial process with an infectious component. While the infectious agents may vary and may not be directly treatable, there are some methods of prevention. Perinatal HIV infection rates have been shown to decrease dramatically with the administration of AZT and nevirapine. Given the fact that the nevirapine protocol is easy to administer, can be initiated at the onset of labour to the mother and from 48–72h post partum to the infant, is less expensive and is quite effective, initiation of this as the standard of care world-wide should greatly reduce the incidence of perinatal transmission of HIV.

Keywords

Infection Perinatal Group B streptococci Necrotising enterocolitis HIV Maternal morbidity

Get full access to this article

View all access options for this article.

References

Miller, JT : History of infection control and its contributions to the development and success of brain tumor operations . Nsurg Focus 2005;18(4): 1–5 .

Hetts S : A millennium of advancement in medical knowledge and education . Medscape Med Students 2000;2(1):www.medscape.com/viewarticle/414663

Symonds EM : Essentials of Obstetrics and Gynecology. Churchill Livingstone, 2004, pp. 62–66.

Chang, J : Pregnancy-related mortality surveillance – United States, 1991–1999 . MMWR Surveill Summ 2003 (21 February);52(2): 1–8 .

Schrag SJ , Zywicki S , Farley MM , Reingold AL , Harrison LH , Lefkowitz LB , Hadler JL , Danila R , Cieslak PR , Schuchat A : Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis . New Eng J Med 2000;342: 15–20 .

Perinatal Group B Streptococcus Infection. Healthlink, University of Wisconsin. http://healthlink.mcw.edu/article/955140524.html.

Noerr B : Part 1. Current controversies in the understanding of necrotizing enterocolitis . Adv Neonatal Care 2003;3(3): 107–120 .

Lindegren ML , Byers RH Jr , Thomas P , Davis SF , Caldwell B , Rogers M , Gwinn M , Ward JW , Fleming PL : Trends in perinatal transmission of HIV/AIDS in the United States . J Am Med Assoc 1999;282: 531–536 .

Sperling RS , Shapiro DE , Coombs RW , Todd JA , Herman SA , McSherry GD , O'Sullivan MJ , Van Dyke RB , Jimenez E , Rouzioux C , Flynn PM , Sullivan JL , Spector SA , Diaz C , Rooney J , Balsley J , Gelber RD , Connor EM : Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant . New Eng J Med 1996;335: 1621–1629 .

10.

Guay LA , Musoke P , Fleming T , Bagenda D , Allen M , Nakabiito C , Sherman J , Bakaki P , Ducar C , Deseyve M , Emel L , Mirochnick M , Fowler MG , Mofenson L , Miotti P , Dransfield K , Bray D , Mmiro F , Jackson JB : Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial . Lancet 1999;354: 795–802 .

11.

Danel I , Berg C , Johnson CH , Atrash H : Magnitude of maternal morbidity during labor and delivery: United States , 1993–1997. Am J Public Hlth 2003;93(4): 631–634 .